The DST Knockout HEK293T Polyclonal Cells consist of a CRISPR/Cas9?mediated gene?disrupted population targeting the dystonin (DST) locus. This polyclonal knockout model provides a loss?of?function platform for studying cytoskeletal dynamics and cell adhesion, preserving genetic heterogeneity to avoid clonal artifacts. The cell population offers a robust system to investigate dystonin?dependent mechanisms in a widely utilized human embryonic kidney epithelial background.
HEK293T cells are derived from human embryonic kidney epithelial cells transformed with sheared adenovirus type 5 DNA and harbor stable expression of SV40 large T antigen, enabling episomal replication of SV40 origin?containing plasmids. These cells are favored for protein overexpression, viral production, and gene editing due to high transfection efficiency and vigorous growth. Their epithelial origin provides a relevant context for examining cytoskeletal and adhesion protein functions.
The DST gene encodes dystonin, a large cytolinker that mechanically integrates intermediate filaments with actin microfilaments and microtubules. Dystonin is regulated by p63 and downstream of integrin signaling. It directly interacts with ??4 integrin (ITGB4) and plectin (PLEC) at hemidesmosomes, forming a complex with collagen XVII (COL17A1) and keratins 5/14 (KRT5, KRT14). Thus, dystonin bridges the ??6??4 integrin complex to the keratin filament network. Disruption of DST disrupts this linkage, leading to defective cytoskeletal organization, impaired cell adhesion, and reduced mechanical stability, as described in the mechanistic summary.
In HEK293T cells, DST knockout yields a simplified epithelial model to probe dystonin??s contributions to adhesion complex stability and cytoskeletal architecture. Although these cells do not assemble mature hemidesmosomes, they express key interaction partners, permitting reconstitution of dystonin?containing complexes. This model is instrumental for investigating pathogenic mechanisms of epidermolysis bullosa simplex with muscular dystrophy and hereditary sensory autonomic neuropathy type VI, where dystonin loss compromises tissue integrity.
Applications include western blotting and immunofluorescence for confirming DST ablation, Sanger sequencing or next?generation sequencing for knockout validation, and functional assays such as cell adhesion, spreading, and migration. Co?immunoprecipitation experiments can dissect protein interaction networks, while cytoskeletal staining reveals filament organization defects. For further technical information or to discuss customized gene?editing services, please contact Ascent Research.
